Dawn Parsell
2021
In 2021, Dawn Parsell earned a total compensation of $2.8M as Executive Vice President, Clinical Development at Tricida, a 28% decrease compared to previous year.
Compensation breakdown
| Bonus | $9,798 |
|---|---|
| Non-Equity Incentive Plan | $202,020 |
| Option Awards | $2,118,253 |
| Salary | $436,800 |
| Other | $552 |
| Total | $2,767,423 |
Parsell received $2.1M in option awards, accounting for 77% of the total pay in 2021.
Parsell also received $9.8K in bonus, $202K in non-equity incentive plan, $436.8K in salary and $552 in other compensation.
Rankings
In 2021, Dawn Parsell's compensation ranked 4,751st out of 12,415 executives tracked by ExecPay. In other words, Parsell earned more than 61.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,751 out of 12,415 | 62nd |
Division Manufacturing | 1,977 out of 5,505 | 64th |
Major group Chemicals And Allied Products | 833 out of 2,375 | 65th |
Industry group Drugs | 746 out of 2,096 | 64th |
Industry Pharmaceutical Preparations | 534 out of 1,546 | 66th |
Source: SEC filing on April 25, 2022.
Parsell's colleagues
We found four more compensation records of executives who worked with Dawn Parsell at Tricida in 2021.
News
Tricida CEO Gerrit Klaerner's 2021 pay falls 47% to $4.7M
April 25, 2022
Tricida CEO Gerrit Klaerner's 2020 pay slips 13% to $8.9M
April 23, 2021
Tricida CEO Gerrit Klaerner's 2019 pay jumps 579% to $10M
April 29, 2020
Tricida Senior Vice President of Clinical Development Dawn Parsell receives $3.7M in 2018
April 18, 2019